BRAVECTO Chews for Dogs: The most commonly reported adverse reactions include vomiting, lethargy, diarrhea, anorexia and pruritus. In some cases, adverse events have been reported following use in ...

BRAVECTO QUANTUM exemplifies Merck Animal Health’s commitment to groundbreaking science and has been recognized as a winner of the 2024 Edison Awards and the 2024 S&P Global Awards for Best New ...

BRAVECTO 1-MONTH is not effective against A. americanum in puppies less than 6 months of age. BRAVECTO Chews for Dogs: The most commonly reported adverse reactions include vomiting, lethargy ...

(RTTNews) - Merck Animal Health, a division of Merck & Co., Inc. (MRK), announced the U.S. Food and Drug Administration's approval of an expanded indication for BRAVECTO Chews for Dogs. . The new ...

BRAVECTO Chews and BRAVECTO Topical Solution for Dogs are safe for pregnant, breeding and lactating dogs. Use with caution in dogs with a history of seizures or neurologic disorders.

BRAVECTO 1-MONTH Chews: indicated for dogs 8 weeks of age and older. The most commonly reported adverse reactions include itching, diarrhea, vomiting, decreased appetite, elevated ALT, lethargy ...

Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck& Co., Inc., Rahway, N.J., USA, today announced the U.S. Food and Drug Administration ...

BRAVECTO QUANTUM is also indicated for the treatment and control of Amblyomma americanum (lone star tick) infestations for 8 months in dogs and puppies 6 months of age and older.

Merck Animal Health, known as MSD Animal Health outside the United States and Canada, a division of Merck& Co., Inc., Kenilworth, N.J., USA,, today announced the U.S. Food and Drug Administration ...